Polymorphisms in the CYP19 gene that influence bone mineral density (Q36772834)

16 August 2017

1 reference

title

Polymorphisms in the CYP19 gene that influence bone mineral density (English)

1 reference

16 August 2017

José A Riancho

1

1 reference

16 August 2017

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

4

1 reference

16 August 2017

339-352

1 reference

How many women have osteoporosis now?

16 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase expression in the human fetal osteoblastic cell line SV-HFO.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Estrogen receptor mutations in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Non-genomic actions of sex steroid hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Skeletal effects of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Clinical review 144: Estrogen and the male skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Interleukin 7 and estrogen-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Mechanisms of sex steroid effects on bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Estrogen: consequences and implications of human mutations in synthesis and action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase activity and bone homeostasis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Bone loss and the aromatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Differential effects of androgens and estrogens on bone turnover in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Alternative usage of different poly(A) addition signals for two major species of mRNA encoding human aromatase P-450.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Role of aromatase in sex steroid action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Transcriptional regulation of aromatase in placenta and ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase expression of human osteoblast-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase in bone: roles of Vitamin D3 and androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aromatase expression and activity in the human leukaemic cell line FLG 29.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Novel concepts for the chemoprevention of breast cancer through aromatase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Estrogen--the good, the bad, and the unexpected.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Genetic Control of Susceptibility to Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Vitamin D receptor and aromatase gene interaction and bone mass in older African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Bone mass in young adults: relationship with gender, weight and genetic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Polymorphisms associated with circulating sex hormone levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor α gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Association analyses of CYP19 gene polymorphisms with height variation in a large sample of Caucasian nuclear families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Variants in the aromatase gene and on the Y-chromosome are not associated with adult height or insulin resistance in a UK population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Relationships among body mass, its components, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Serum leptin level is a predictor of bone mineral density in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Leptin, bone mass, and the thrifty phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

Common Genetic Variation of the Low-Density Lipoprotein Receptor-Related Protein 5 and 6 Genes Determines Fracture Risk in Elderly White Men

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.4.339

21 January 2018

Identifiers

DOI

10.2217/14622416.8.4.339

1 reference

16 August 2017

1 reference

PubMed ID

17391072